Literature DB >> 8233393

Vitreous surgery for macular holes.

R T Wendel1, A C Patel, N E Kelly, T C Salzano, J W Wells, G D Novack.   

Abstract

BACKGROUND: To surgically treat patients with macular holes, the authors previously reported both anatomic (re-attachment) and visual success (2 lines of improvement) in a series of 52 eyes. They now have operated on an additional 118 eyes using similar techniques, for a total of 170 eyes.
METHODS: After ophthalmologic examination and history, the authors operated on suitable patients. The surgical objectives included relief of all tangential traction and retinal tamponade with intraocular gas. All eyes were followed for at least 6 months postoperatively.
RESULTS: In the total population of 170 eyes, anatomic success was achieved in 73% and vision improved at least two lines in 55%. Twenty-nine percent (49/170) of patients had a visual acuity of 20/40 or better at last examination. Patients with symptoms of less than 6 months' duration managed better than those with symptoms of longer duration (P = 0.3001). In the former group of 66 eyes, anatomic success was achieved in 80% (n = 53), whereas visual acuity improved at least two lines in 68% (n = 45) and at least four lines in 55% (n = 36).
CONCLUSIONS: The authors suggest that macular hole surgery may provide meaningful improvement in visual acuity in most patients, especially in those whose symptoms are of less than 6 months' duration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8233393     DOI: 10.1016/s0161-6420(93)31419-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  72 in total

Review 1.  Idiopathic full thickness macular hole: natural history and pathogenesis.

Authors:  E Ezra
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

2.  Estimation of the retinal nerve fibre layer thickness in the papillomacular area of long standing stage IV macular holes.

Authors:  A Assi; P Watts; J McAllister
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

3.  Macular hole size as a prognostic factor in macular hole surgery.

Authors:  S Ullrich; C Haritoglou; C Gass; M Schaumberger; M W Ulbig; A Kampik
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

4.  Macular hole and myopic refraction.

Authors:  H Kobayashi; K Kobayashi; S Okinami
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

5.  Comparison of anatomical and visual outcomes of macular hole surgery in patients with high myopia vs. non-high myopia: a case-control study using optical coherence tomography.

Authors:  Tsung-Tien Wu; Ya-Hsin Kung
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-21       Impact factor: 3.117

6.  Visual and anatomical results of surgery for long standing macular holes.

Authors:  R A Scott; E Ezra; J F West; Z J Gregor
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

7.  Correlation between central retinal thickness after successful macular hole surgery and visual outcome.

Authors:  Yoshihiro Takamura; Takeshi Tomomatsu; Takehiro Matsumura; Shogo Arimura; Makoto Gozawa; Yuji Takihara; Masaru Inatani
Journal:  Jpn J Ophthalmol       Date:  2015-08-29       Impact factor: 2.447

8.  Late reopening of successfully treated macular holes.

Authors:  M Paques; P Massin; P Y Santiago; A C Spielmann; J F Le Gargasson; A Gaudric
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

9.  [Long-term functional results after macular hole surgery. Results of a prospective study].

Authors:  I W Reiniger; C A Gass; M Schaumberger; A Kampik; C Haritoglou
Journal:  Ophthalmologe       Date:  2006-06       Impact factor: 1.059

10.  Comparisons of cone electroretinograms after indocyanine green-, brilliant blue G-, or triamcinolone acetonide-assisted macular hole surgery.

Authors:  Shigeki Machida; Yoshiharu Toba; Tomoharu Nishimura; Takayuki Ohzeki; Ken-ichi Murai; Daijiro Kurosaka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-02       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.